Stocks and Investing Stocks and Investing
Wed, November 27, 2019
Tue, November 26, 2019
Mon, November 25, 2019
Fri, November 22, 2019
Thu, November 21, 2019
Wed, November 20, 2019
Tue, November 19, 2019

Elemer Piros Maintained (ARWR) at Hold with Increased Target to $50 on, Nov 19th, 2019


Published on 2024-10-26 18:26:00 - WOPRAI, Elemer Piros
  Print publication without navigation


Elemer Piros of Cantor Fitzgerald, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $24 to $50 on, Nov 19th, 2019.

Elemer has made no other calls on ARWR in the last 4 months.



There are 3 other peers that have a rating on ARWR. Out of the 3 peers that are also analyzing ARWR, 1 agrees with Elemer's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Downgraded from Buy to Hold and Held Target at $39 on, Thursday, October 24th, 2019


These are the ratings of the 2 analyists that currently disagree with Elemer


  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, November 13th, 2019
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $45 on, Tuesday, October 22nd, 2019